Chapter 255 Yibaizhongb became popular overseas
One hour later, the dinner ended.
I have to say that Minako's conversation and insight surprised Zhang Yang.
I originally thought that what Friedman introduced to him was just a vase, but I didn't expect that Minako not only had a very good understanding of Chinese and Japanese culture, but also had his own insights into drug research and development. For a time, the two of them kept talking about it. The whole dinner was very harmonious.
Even until the dinner ended, Zhang Yang still felt a little unfulfilled.
"Mr. Zhang, will I accompany you after dinner?"
"Okay."
Zhang Yang did not refuse.
After walking out of the Chinese restaurant, the lights were off, the two of them walked to the Hilton Hotel where Minako was staying before stopping.
The breeze at night gently blew on Minako's face, and the lights at the entrance of the hotel made her look more charming.
"Mr. Zhang, do you want to go up and sit down and have a cup of tea before leaving?"
"No."
This time Zhang Yang shook his head, and he knew very well that the two of them were not familiar with each other yet. To this extent.
Minako seemed to think that Zhang Yang would refuse, and smiled and said, "Then I'll take you into the car first."
"It's okay, I'll just take a taxi home by myself."
After a while, a yellow taxi parked at the door of the hotel. After watching Zhang Yang leave, Minako let out a heavy breath. Turning around and walking into the hotel.
…
Although Minako left a good impression on Zhang Yang, it was just a small episode.
In the next two days, Zhang Yang quickly put this matter behind his mind and began to think about his next focus.
At present, the clinical trial of "Yibaimab" has come to an end, and the P4 biological laboratory is about to start construction. Should we start to draw personnel to study the "T14 pneumonia virus"?
By the way,
There is also the matter of Prince Amir of the Saudi royal family.
I received $5 billion to develop drugs that will completely cure hemophilia. Now the R&D team is almost formed. Should I participate and promote the progress of the project?
While Zhang Yang was hesitating, he did not expect that the impact of the combination treatment of "Yibaizumab" is not over yet.
overseas.
Leukemia Patients Alliance.
When "Ibaimab" was just undergoing clinical trials, foreign patients were very concerned about the progress of "Ibaimab".
When the later combination treatment plan caused the side effects of bone marrow failure, many overseas patients were very worried about whether the clinical trial of "Yibaizumab" would fail and not continue.
At this time, the clinical trial of "Yibaimab" has resumed, and all overseas leukemia patients were relieved.
At the same time, the envy and jealousy hidden in my heart surged into my heart again.
"I don't understand."
"Why can't our country have pharmaceutical companies like Qingshan Pharmaceutical appear, and we can't accept clinical trials of such top-level drugs."
"I don't understand, what's wrong with our country? What's wrong with our ZF? Our society is all sick."
"Hey, I really want to go to China. I love this country. No one can tell me how to get to China and how to use Qingshan Pharmaceutical's 'Yibaizumab'! ”
"I also want to use Qingshan Pharmaceutical's 'Yibaimab', who doesn't want it?! The basic treatment rate of 83%, maybe I can reach more than 95%!"
"I'm too I envy the leukemia patients in China. They are much luckier than us because they have Qingshan Pharmaceutical! "
"Yes, I answered the one upstairs just now, it is not difficult to go to China. Now there are 144 Transit visa for a young age is rare. How can we get a clinical trial quota! As far as I know, there are many leukemia patients in China, and many people are waiting for a quota! "
" Alas, I understand... We should call on ZF to introduce Qingshan Pharmaceutical as soon as possible. Isn't Qingshan Pharmaceutical worthy of having a branch in Europe? "
"Yes! It is recommended that ZF give Qingshan Pharmaceutical the best Conditions introduce them so that we can be saved! ”
There are all things in the Overseas Leukemia Alliance.
However, some people are calling, while others are starting to act.
New York, in a beautiful villa.
Huang Jinsong is a top expert in the chip field. He began to immerse himself in the semiconductor industry as early as the 1990s. More than 30 years have passed, and before he knew it, he has become a leader in the industry.
Looking at the news on the computer screen about Qingshan Pharmaceutical's "Yibaimumab" solving the side effects and restarting clinical trials, he thought for a long time, and finally slowly took out his cell phone and found a phone call in the address book to dial it. Go past.
As soon as the ringtone rang, the other end of the phone immediately opened, and then a burst of excitement came.
"Hello, Mr. Huang, have you figured it out? Are you willing to join our team?"
Huang Jinsong breathed gently and nodded:
< br>"Well, I thought about it for a long time, and I agree to join you Huawei and assist you in developing the latest generation of chips."
A more excited voice suddenly came from the other end of the phone.
"Okay, okay, finally wait for you!"
"Don't worry, the shares and positions we mentioned to you were kept for you. Once you return to China, as long as you sign, it will take effect immediately."
Huang Jinsong couldn't help but shake his head. Even through the phone, he could feel that this was not what he valued the most:
"Thank you."
"But before I returned to China, I have a simple request, and I hope you can help me solve it."
As she said that, Huang Jin paused: "My daughter unfortunately diagnosed with 'acute myeloid leukemia' last year. She relapsed after the bone marrow transplant surgery two months ago."
"Currently I don't want her to undergo a second bone marrow transplant... I saw on the Internet that Qingshan Pharmaceutical, a top pharmaceutical company in China, recently developed a drug that can treat acute leukemia. The clinical trial results announced are very good... …”
"So I think, or I hope you can help contact Qingshan Pharmaceutical and help my daughter get a drug quota for clinical trials!"
"As long as you can agree to this I can return to China tomorrow.”
The middle-aged man on the other end of the phone was obviously surprised.
He knew Qingshan Pharmaceutical, but he did not know what the so-called drugs to treat leukemia.
"Mr. Huang, wait a moment, I will write down your request!"
"Don't worry, no matter what, we will do our best to apply for a clinical place for your daughter. ! ”
Huang Jinsong finally showed a smile on his face, and his tone relaxed for the first time.
"Okay, then I'll wait for your good news."
"I still said the same thing. I agree to join Huawei, but I hope you can also help me contact Qingshan Pharmaceutical to solve the clinical trial quota. Question!
"Okay, I will reply you at noon tomorrow at the latest. ”…
Early the next morning.
As soon as Zhang Yang arrived at the company, he learned from his assistant Xiao Chen that two bosses who had just arrived from the Shenzhen Stock Exchange were waiting in the living room.
After accompanying him, an office director in the city was also present.
He was a little surprised and quickly walked to the living room, and said directly without politely: "Two people are..."
"Mr. Zhang! You take the liberty to bother you..." , We are the department head of Huawei. My surname is Lu, Luxing, and I am mainly responsible for some of Huawei's market outreach work."
"This surname is Ma, Ma Rengang, and is a boss of our Human Resources Department."
Market Department, Human Resources Department?
Zhang Yang was even more confused, but when Lu Xing from the marketing department finished the purpose of the trip, he changed from doubt to surprise. "So the two of you came here this time just to hope that we can open a back door and give the daughter of the boss who has not yet served a clinical trial quota?"
"Yes!" Ma Rengang nodded urgently.
No mistakes, one song, one content, one in 6, one book, one bar, one reading!
Zhang Yang pondered a little, frowned and said, "It's not impossible! But... the quota of subjects in our second phase of clinical clinical subjects is now full."
"It's not impossible! >Before he finished speaking, Lu Xing, the marketing manager on the side, had already understood it and hurriedly said: "Mr. Zhang, don't worry!"
"Although our Huawei has few business intersections with your company, I have done my homework before coming."
"You should have heard that many foreign pharmaceutical companies have introduced AI intelligence to apply AI in innovation In the screening of drug compounds, Huawei also has certain technical reserves in this regard. "
"If you need it in the future and Qingshan Pharmaceutical needs it, we will definitely do our best to help your company build an AI model." >
Zhang Yang was stunned. He actually didn't mean this.
Because the clinical trial plan itself is to first formulate the number of clinical trials and then recruit subjects, everything has detailed regulations!
but.
Since Lu Xing said this, he could not refuse again.
The eyebrows were slightly loosened, and a smile appeared on his face.
"Okay, since President Lu and President Ma both came to the door in person, it would be impossible not to give it some convenience."
"Let's do this, I'll give a report to the review center, and We said that there is a special patient here who needs to participate in independent medication, so we can use independent medication quotas to conduct clinical trials! ”
Upon hearing this, Mr. Lu and Mr. Ma who came to visit him kept nodding.
They don't care what method Zhang Yang uses, just agree.
"Okay, okay, okay! Then I'm so grateful to Mr. Zhang!"
...
A common patient's clinical trial for "Ibaimab" I tried every possible way to find the quota.
In the global hematologic industry.
Royal Hospital, London, UK.
As early as when "Ibaimab" just participated in the clinical trial, Richard, chief doctor of the Department of Hematology, flew to the Third People's Hospital of Rongcheng to learn about the actual clinical trial effects of "Ibaimab".
After coming back, he wrote two papers on the clinical effect of "Yibaizumab" in one breath, which was praised and questioned by many colleagues.
After hearing the side effects of bone marrow failure of "Yibaizumab", he was not surprised because he had discussed with Director Hu about the possibility of side effects when he was at Rongcheng Third People's Hospital before. .
On the contrary, Qingshan Pharmaceutical used "ITG human bone marrow entropin", which surprised him so easily.
After the news was confirmed, he could no longer sit still.
"No, I have to go to China again!"
"Now their combined treatment plan is much more mature than when I went there before, and the effect has been significantly improved!"
"Now the side effects problem has also been solved. I must go to China as soon as possible to learn the latest treatment plan. Only in this way can I bring the latest treatment plan for leukemia back to Europe!"
"Are you going again?"
In the office, the doctors looked at Dr. Richard with envy.
Dr. Richard is well-known among the world's hematology doctors. Because of this, only he can go to China at will and have the resources to exchange and study in the best hematology departments in China.
I am afraid I will have to write a lot of papers when I come back this time.
Everyone is envious and a little jealous.
At this moment, a doctor's surprise suddenly sounded in the office!
"Dr. Richard, look at Director Hu of the Third People's Hospital of China Rongcheng, right! He is the director of the hospital you went to China before!"
"He just said A paper about 'Ibaimab' was published, with the name..."
"Oh, MyGOD! The name of the paper turned out to be Chinese, and it translated into: 'Ibaimab allogeneic T cells Research on the molecular mechanism of immune synapse formation'!
And the paper was not published in the Lancet's special issue of hematopathy, but was published in a Chinese medical journal of China! "
< br>
Dr. Richard was shocked and then quickly took the tablet computer in his colleague's hand.
After a few simple glances, I suddenly took a few breaths:
"I'll come whatever I say!"
"I said last time, Thirty years after Hedong and thirty years after Hexi, before, the doctors in China tried their best to learn our most advanced treatment plans for hematological diseases. "
"But now it's our turn to learn from them!" >
"Look, the most important leukemia treatment plan and treatment data papers in the hematology department are all in Chinese and published in the Chinese journal "China Frontier Medicine" in China!"
"What willow leaves are there? They don’t vote for the New England Journal of Medicine! "
"This means that if we want to understand the latest leukemia treatment plans and data, we must learn Chinese, and when we write papers in the future, we will inevitably go around. If you don’t open these top papers in the journal “China Frontier Medicine”! ““You will even quote them as documents in large quantities!” Richard suddenly felt a little sad inside.
He shrugged and sighed: "Shit, why do I suddenly feel that the center of future medicine is about to be transferred to the East?!" "Now the treatment of blood diseases in China is already The best country in the world, what kind of disease is next? ! ”
…
And just as Dr. Richard sighed, on the other side, >
Zhang Yang from Qingshan Pharmaceutical unexpectedly received a special invitation letter.
The person who posted the invitation letter was - Huaxia Frontier Medical Journal.
(This chapter ends)